Introduction
Nuclear receptors, a cl ass of the steroid/ th yroid hormone receptor families, play an important role in cell differentiation as transcription factors (Hazel et al., 1988; The Nuclear Receptor Nomenclature Committee, 1999) . Among them, the nerve growth factor-induced gene B (NGFI-B) group contains four orphan receptors (NR4A1, NR4A2, NR4A3, NR4A4), and the retinoid X receptor (RXR: NR2B) also has been shown to be a partner of NR4A1 and NR4A2 (Willams and Lau, 1993; Davis and Lau, 1994; Woronicz et al., 1994; Lee et al., 1995) . NR4A2 is also known as NOT, NGFI-B , TINUR, NURR1 in humans, NURR1 and NGFI-B in mice and NGFI-B , NURR1 and HZF-3 in rats (Mages et al., 1994) . This receptor the term NGFI-B is used in the present study is inducible by serum growth factors, participates in cell signaling (Willams and Lau, 1993) , and is affected by endocrine and neurogenic regulation (Davis and Lau, 1994) . NGFI-B is also almost exclusively expressed in the brain, and may play an essential role in the development of midbrain dopaminergic neurons (Zetterstrom et al., 1997; SaucedoCardenas et al., 1998; Le et al., 2003) . Mice lacking NGFI-B failed to generate midbrain dopaminergic neurons, suggesting that NGFI-B is essential for the maturation, migration, and cell survival of developing mesencephalic dopamigenic cells (Zetterstrom et al., 1997; Wallen et al., 1999) . However, the precise expression of this nuclear receptor as well as its function has not been fully clarified. Although Zetterström et al. (1996) demonstrated the expression of NGFI-B mRNA in fetal and adult animals by in situ hybridization, the expression of NGFI-B at the protein level has not been described. Here we immunohistochemically studied and h (Vectastain Elite ABC Kit, Vector, CA, USA). To prevent endogenous peroxidase reactions, the samples were pretreated with 0.3% H2O2 in cold methanol for 30 min and were subsequently incubated with avidin and horseradish peroxidase (HRP)-conjugated biotin for 30 min. Finally, 0.1 mg/ml 3,3'-diaminobenzidine (DAB) tetrahydrochloride was applied to sections for 5 min. In order to identify NGFI-B -associated immunostaining, the sections were counterstained with haematoxylin.
Immunohistochemical double staining was performed o n t h e a b o v e p a r a f f i n -e m b e d d e d s e c t i o n s u s i n g immunoperoxidase method. We used a mouse monoclonal antibody against rat NGFI-B described above for the first primary antibody and a mouse monoclonal antibody against rat proliferating cell nuclear antigen (PCNA) (1:100, Dakopatts, Carpinteria, CA, USA) for the second primary antibody. Deparaffinized sections (4 m thick) were pretreated with pressure cooker antigen retrieval (0.1M citrate buffer solution, PH 6.0) for 30 min, 5% hydrogen peroxide in methanol for 20 min to inhibit endogenous peroxidase, and then with 1% bovine serum albumin/PBS for 30 min to minimize non-specific staining. The sections were incubated overnight with the NGFI-B antibody, incubated with the HRP-conjugated secondary antibody (Nichirei, Tokyo) for 40 min at room temperature, and colored with DAB. Thereafter, the same sections were treated with microwave oven antigen retrieval (0.1M citrate buffer solution, PH 6.0) for 20 min and then with 1% BSA-PBS for 30 min again. The sections were incubated with the PCNA antibody overnight and with the HRP-conjugated secondary antibody as described previously.We used 4-chloro-Inaphthol for visualization, and the reaction was observed by light microscopy.
Immunoblotting
Whole cell extracts were obtained from CHO cells which were transfected with either the human NGFI-B , NGFI-B or NGFI-B expression vector. The total lysate of the rat brain was resolved by SDS-polyacrylamide gel electrophoresis (10%) and electroblotted on to ProBlott membranes. The membranes were blocked with Block Ace (Dainippon Pharmaceutical, Osaka) for 16 h at 4 , probed with 1 g/ml of the primary monoclonal antibody and then incubated with the anti-mouse IgG HRP-conjugated antibody (Sigma, St. Louis, MO USA). Proteins were detected using SuperSignal ® West Dura Extended Duration Substrate (Pierce, Rockford, IL, USA).
report on NGFI-B expression in neuronal cells both in the brain and retina, suggesting that NGFI-B plays an important role in the postmitotic differentiation of neuronal cells.
Materials and Methods

Human tissue samples
The use of human and animal tissues for this study was approved by the Ethics Committee of the Research Center for Advanced Science and Technology at the Niigata University (No. 226). Human tissues were obtained from the Division of Cellular and Molecular Pathology at Niigata University Graduate School of Medical and Dental Sciences. Normal human tissues were obtained from surgical and biopsy cases, and autopsy cases in which the autopsy was conducted within 5 h of death. Tissue sections from the stomach, colon, pancreas, ovary, uterine, lung, breast, prostate, thyroid, liver, and kidney were obtained.
Animals
Wistar rats (Charles River Breeding Laboratories, Chiba) were used. They were housed on a 12/12 h light/dark cycle, with free access to food and water. This study was approved by the Institutional Review Board for Animal Experiments at Niigata University.
The rats were deeply anesthetized by an inhalation of diethyl ether (Wako Pure Chemical Industries, Osaka), and were sacrificed by cervical dislocation. Adult rats (n 5), fetal rats from 10 to 19 days of gestation (n 2, for each day, 5 of the fetuses were used), and postnatal rats at 0.5 day to 17.5 days (n 5 for each day), were used. Tissues were removed and fixed with 10% formalin.
Immunohistochemistry
Tissues were fixed for 1 day at room temperature in 10% formalin in a 0.1M phosphate-buffered solution (PBS), PH 7.4. The samples were sequentially dehydrated with an alcohol series and embedded in paraffin wax. The sections (4 m thick) were treated with normal horse serum to minimize non-specific staining. These tissues were incubated with a monoclonal antibody against human NGFI-B (1:100, N1404, Perseus Proteomics, Tokyo) dissolved in 1% BSA/PBS at a final concentration of 10 g/ml for 2 h at 25 or overnight at 4 . After washing with PBS, the sections were stained with biotinylated anti-mouse IgG for 1
Immunoblotting revealed a distinct band corresponding to 59 and 66 kDa in the tissue samples of the rat brain (Fig.  1b) . Although the molecular size of NGFI-B protein is supposed to be 66 kDa in rats, Mages et al. (1994) reported the presence of a 59 kDa isoform. These findings suggested that the antibody is specific for human and rat NGFI-B protein.
Expression of NGFI-Bβ in human and rat tissues
In humans, immunohistochemical expression of NGFI-B was detected in the nucleus of neuronal cells in the brain and retina as well as cells in the adrenal cortex (Fig.  2a, c, e) . NGFI-B -positive cells were distributed in the Figure 1a indicates the results of immunoblotting with the anti-human NGFI-B antibody using proteins obtained from CHO cells transfected with the human NGFI-B , NGFI-B and NGFI-B expression vectors. The antibody bound specifically to human NGFI-B protein, which had an apparent molecular weight of 55 75 kDa. The antibody did not cross-react with human NGFI-B or NGFI-B . Because amino acid sequences of human NGFI-B protein are highly similar to rat NGFI-B , the antibody also recognized rat NGFI-B . Table 1 . Our immun ohi s toch emical and w es t ern b lot analys es demonstrated that this anti-human NGFI-B antibody is a useful marker for detecting NGFI-B protein of rat tissues.
Results
NGFI-Bβ-specific antibody for human and rat tissues
Expression of NGFI-Bβ in embryonic and neonatal rats
Brain NGFI-B expression was first observed in a few cells in the midbrain at embryonic day 12 (E12). At E13, NGFI-B -positive cells were observed in the thalamus, hypothalamus, medulla oblongata and spinal cord (Fig. 3) ; however, there were no labeled cells within the cerebral cortex or hippocampus, or in the peripheral nervous system at this stage. The number of NGFI-B -expressing cells increased in the midbrain and medulla oblongata as well as in the spinal cord at E15 (Fig. 4) . NGFI-B expression was not observed in the neocortex at E15 (Fig.  4 , 5. a, b) but was found in the neurons in the deepest layer of the neocortex at E17 (Fig. 5c,d ). There was no labeling in the embryonic hippocampus. At E18, there was also intense labeling within the ventral tegmental area and brainstem.
The expression of NGFI-B was remarkable in neurons in the neonatal cortex. Positive cells were found throughout the cortex at post natal day 1 (P1) but were confined to layer VI up to P9; NGFI-B expression was decreased but persisted into adulthood (Fig. 5g, h ). There was also a strong labeling in the claustrum during the late stage of development and in adulthood. NGFI-B -labeled cells were also distributed in the hypothalamic area, substantia nigra, and tegmentum. NGFI-B -expressing cells were also found close to the fourth ventricle.
In the spinal cord of the neonatal rats, NGFI-B labeling was found in central parts of the grey matter, but was no longer detected after P9.
Retina
In embryonic rats, the retina was composed of a thin granular cell layer and a nuclear layer. The nuclear layer was separated into inner and outer nuclear layers after birth. A small number of NGFI-B -positive cells were detected in the nuclear layer from E18, peaked at P3.5 to P7.5, and gradually decreased. A small proportion of NGFI-B -labeled cells were detected in the ganglion cell layer from P0.5 to adulthood (Fig. 7) . midbrain, thalamus, and hypothalamus, layer VI of the cerebral cortex and claustrum but not in the cerebellum. In the retina, a few cells in the ganglion cell layer and inner nuclear layer were positively stained. A few stellate or spindle-shaped cells were positive for the NGFI-B antibody in the thymic medulla and cortex. These cells were negative for CD68 (unpublished data), implying that they are reticular cells.
In rat tissues, the immunohistochemical expression of NGFI-B was similar to that in human tissues (Fig.  2b, d, f) . In the brain, NGFI-B positive cells were distributed in the claustrum and cerebrum, particularly in layer VI of the entire cortex, and midbrain. No NGFI-B labeling was found in the spinal cord and cerebellum. As observed in humans, a few NGFI-B -positive cells were observed in the inner nuclear layer and ganglion cell layer of the retina. A comparison of immunohistochemistry 
Cell proliferation and NGFI-Bβ expression of neuronal cells
We t he n e xa min e d t h e r e la t io n s h ip b e t we en cell proliferation and NGFI-B expression of neuronal cells in the rat brain and retina. In the brain, PCNA-positive proliferating cells were distributed mainly in the deep layer of the ventricular zone in the early embryonic days (Fig. 6a -d) . In contrast, NGFI-B -expressing cells were located in the midbrain and other sites described above and were not labeled with PCNA. PCNA-positive cells disappeared after birth in the cerebral cortex (Fig. 6e) , while NGFI-B -expressing cells were densely distributed in II -III layers and sparsely in IV -VI layers of the cerebral cortex and habernum nucleus at P1 (Fig. 6f) . Gradually, the number of NGFI-B positive cells in II -III layers decreased and disappeared. NGFI-B -positive cells were gradually confined to the VI layer of the cerebral cortex by P9 (Fig. 5g, h ). NGFI-B -labeled cells were detected in the inner nuclear layer from E18 and in the ganglion cell layer of the retina after birth. In contrast, PCNA-positive cells were abundant in the inner and outer nuclear layers up to P1 and confined to the inner nuclear layer thereafter. The number of PCNA-expressing cells decreased after birth and completely disappeared by P17. Immunohistochemical double staining clearly demonstrated that almost all NGFI-B -positive cells were not labeled with the anti-PCNA antibody (Fig. 7,  Table 2 ).
These findings indicated that the expression of NGFI-B and cell proliferation represented dynamic changes both in the brain and retina at different developmental stages.
Discussion
The present study demonstrated that NGFI-B protein was expressed in highly specific patterns in the central nervous system. NGFI-B protein was expressed in the nucleus, while NGFI-B mRNA appeared to be exclusive to the neuronal cell body (Zetterstrom et al., 1996) . Zetterström et al. (1996) confirmed by in situ hybridization that NGFI-B (Nurr1) mRNA exists in several regions of the fetal and adult central nervous system of mice and rats. Using a novel antibody, the present study demonstrated that the expressions of NGFI-B mRNA and protein were almost identical in rat tissues. . Expression of NGFI-B and cell proliferation in the developing rat retina. In the retina, NGFI-B -labeled cells (brown, arrows) were detected in the inner nuclear layer from E18 (a) and in the ganglion cell layer after birth (b-i). PCNA-positive cells (dark purple) were abundantly present in the inner and outer nuclear layers (a, b) up to P1 and were confined to the inner nuclear layer after birth (c-g). PCNA-expressing cells disappeared by P17 (h, i).
Immunohistochemical double staining using anti-NGFI-B antibody and anti-PCNA antibody. GCL: ganglion cell layer, INL: inner nuclear layer, ONL: outer nuclear layer. Scale bars: 50 m Midbrain dopamine cells are abnormally distributed and the expression of several genes involved in dopamine metabolism are absent in Nurr1 (NGFI-B ) gene knockout mice (Nurr1 / ) (Saucedo-Cardenas et al., 1998; Wallen et al., 1999) . Mice lacking the gene fail to generate brain dopaminergic neurons, are hypoactive, and die soon after birth (Zetterstrom et al., 1997) , suggesting that NGFI-B plays a critical role in midbrain dopaminergic neuron development. Dopaminergic neurons of the retina are believed to be amacrine cells, and these cells contain tyrosine hydroxylase, the rate-limiting enzyme in dopamine biosysnthesis (Eglen et al., 2003) . There are abundant dendro-somatic dopamigenic cell-to-AII amacrine cell synapses in the inner plexiform layer (Wilson et al., 1993; Crawford et al., 1995) . However, no NGFI-B expression in the retina has been reported so far.
Considering that NGFI-B plays an essential role in the development and maintenance of midbrain dopaminergic neurons, dopamigenic amacrine cells are candidates of NGFI-B -expressing cells in the retina. In the present study, NGFI-B expression was confirmed in some cells in the inner granular layer and ganglion cell layer. In the retina, dopamigenic amacrine cells are also reported to be present in both these locations. Eglen et al. (2003) regarded that dopaminergic amacrine cells in both the inner granular layer and ganglion cell layer as belonging to a single functional type. Further studies are needed to confirm the cell type of the NGFI-B -expressing cells in the retina. The expression of NGFI-B was not limited to the midbrain, thalamus, hypothalamus, pons, medulla oblongata and spinal cord, but was also found in the cerebral cortex. In contrast to our understanding of the NGFI-B function in dopaminenic cells in the midbrain, the functional role of NGFI-B expression in the neocortex is unknown. We observed that the number of NGFI-B -positive cells increased throughout the cortex after birth and were confined to layer VI in adulthood. In the retina, NGFI-B -positive cells were detected from E18, peaked in the neonatal period, and decreased in adulthood. Cellular dynamics of NGFI-B -expressing cells in the neocortex and retina appear to be very similar. Such a striking expression of NGFI-B in the cortex and retina suggests that this receptor is involved in some specific function in the central nervous system. Recent studies have suggested that NGFI-B could induce a mature and highly differentiated dopaminergic phenotype in neural stem cells and neural precursors by inducing cell cycle arrest in the G1 phase in immortalized dopamine MN9D cells (Chung et al., 2002; Haas et al., 2002; Kim et al. 2003) . The lack of NGFI-B expression in dopamine MN9D cells was associated with undifferentiated cell morphology, whereas NGFI-Bexpressing cells are characterized by a well differentiated morphology (Castro et al., 2001) . In this study we demonstrated that most of the NGFI-B expressing cells were not labeled with PCNA, a proliferation marker. Highly expressed NGFI-B in the developing brain and retina may prevent neural cell proliferation.
In conclusion, NGFI-B is highly expressed in nonproliferating neuronal cells of the developing brain and retina, implying that this nuclear receptor might be a key molecule in the postmitotic development, maturation and function of neuronal cells.
